Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Applied Therapeutics Inc (NASDAQ: APLT)

 
APLT Technical Analysis
2
As on 2nd Dec 2024 APLT SHARE Price closed @ 1.75 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.11 & Buy for SHORT-TERM with Stoploss of 1.44 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

APLTSHARE Price

Open 2.04 Change Price %
High 2.09 1 Day -0.28 -13.79
Low 1.68 1 Week -7.68 -81.44
Close 1.75 1 Month -6.88 -79.72
Volume 29751868 1 Year 0.28 19.05
52 Week High 10.24 | 52 Week Low 1.26
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
OPTT 0.70 40.00%
SMCI 42.00 28.68%
NVDA 138.63 0.27%
INTC 23.93 -0.50%
MARA 25.63 -6.53%
LMDX 0.02 0.00%
PLUG 2.30 2.68%
SGBX 0.68 41.67%
TSLA 357.09 3.46%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
FTCI 3.43 1006.45%
CTXRW 0.14 600.00%
GFAIW 0.17 240.00%
NDRAW 0.03 200.00%
PPBT 9.87 193.75%
PPBT 9.87 193.75%
GLSPT 33.43 138.62%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
ZWZZT 17.90 -53.95%
MILEW 0.06 -53.85%
PXSAW 0.25 -50.00%
MYPSW 0.01 -50.00%
LOTZW 0.01 -50.00%
 
 
APLT
Daily Charts		 APLT
Intraday Charts		 Whats New @
Bazaartrend		 APLT
Free Analysis
 
APLT Important Levels Intraday
RESISTANCE2.54
RESISTANCE2.29
RESISTANCE2.13
RESISTANCE1.97
SUPPORT1.53
SUPPORT1.37
SUPPORT1.21
SUPPORT0.96
 
APLT Forecast December 2024
Share
4th UP Forecast3.62
3rd UP Forecast3.02
2nd UP Forecast2.65
1st UP Forecast2.28
1st DOWN Forecast1.22
2nd DOWN Forecast0.85
3rd DOWN Forecast0.48
4th DOWN Forecast-0.12
 
APLT Weekly Forecast
4th UP Forecast2.31
3rd UP Forecast2.13
2nd UP Forecast2.02
1st UP Forecast1.91
1st DOWN Forecast1.59
2nd DOWN Forecast1.48
3rd DOWN Forecast1.37
4th DOWN Forecast1.19
 
APLT Forecast2024
4th UP Forecast19.94
3rd UP Forecast14.11
2nd UP Forecast10.5
1st UP Forecast6.89
1st DOWN Forecast-3.39
2nd DOWN Forecast-7
3rd DOWN Forecast-10.61
4th DOWN Forecast-16.44
 
 
APLT Other Details
Segment EQ
Market Capital 405494112.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
APLT Address
APLT
 
APLT Latest News
 
Your Comments and Response on Applied Therapeutics Inc
 
APLT Business Profile
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase I/II for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York. Address: 545 Fifth Avenue, New York, NY, United States, 10017
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service